FDA Orange Book
Generic for Trilafon
Trilafon contains perphenazine. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Trilafon is perphenazine. 9 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB. Generics match 4 of the 8 Trilafon products the Orange Book lists.
Run it in Rivvi
Map Trilafon and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Trilafon products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| concentrate, oral | 16MG/5ML | Discontinued | None | 0 | None |
| injectable, injection | 5MG/ML | Discontinued | None | 0 | None |
| syrup, oral | 2MG/5ML | Discontinued | None | 0 | None |
| tablet, extended release, oral | 8MG | Discontinued | None | 0 | None |
| tablet, oral | 16MG | Discontinued | None | 9 | AB |
| tablet, oral | 2MG | Discontinued | None | 9 | AB |
| tablet, oral | 4MG | Discontinued | None | 9 | AB |
| tablet, oral | 8MG | Discontinued | None | 9 | AB |
NDA 011557, 011213, 011294, 011361, 010775, held by SCHERING CORP SUB SCHERING PLOUGH CORP. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic perphenazine
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| SANDOZ INC | 089685 | AB (A-rated, therapeutically equivalent) | December 8, 1988 | 16MG, 2MG, 4MG, 8MG |
| PH HEALTH LTD | 040226 | AB (A-rated, therapeutically equivalent) | December 31, 1998 | 16MG, 2MG, 4MG, 8MG |
| WILSHIRE PHARMACEUTICALS INC | 205973 | AB (A-rated, therapeutically equivalent) | December 17, 2015 | 16MG, 2MG, 4MG, 8MG |
| WATSON LABORATORIES INC | 207582 | AB (A-rated, therapeutically equivalent) | October 17, 2016 | 16MG, 2MG, 4MG, 8MG |
| RISING PHARMA HOLDINGS INC | 205056 | AB (A-rated, therapeutically equivalent) | March 1, 2019 | 16MG, 2MG, 4MG, 8MG |
| ZYDUS PHARMACEUTICALS USA INC | 205232 | AB (A-rated, therapeutically equivalent) | April 6, 2020 | 16MG, 2MG, 4MG, 8MG |
| SOMERSET THERAPEUTICS LLC | 210163 | AB (A-rated, therapeutically equivalent) | May 18, 2022 | 16MG, 2MG, 4MG, 8MG |
| MACLEODS PHARMACEUTICALS LTD | 212545 | AB (A-rated, therapeutically equivalent) | May 6, 2024 | 16MG, 2MG, 4MG, 8MG |
| JUBILANT GENERICS LTD | 213694 | AB (A-rated, therapeutically equivalent) | March 18, 2025 | 16MG, 2MG, 4MG, 8MG |
Questions
Is there a generic for Trilafon?
Yes. The generic name for Trilafon is perphenazine. 9 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB. Generics match 4 of the 8 Trilafon products the Orange Book lists.
What is the generic name for Trilafon?
The active ingredient in Trilafon is perphenazine, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.